These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34859477)

  • 1. Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management.
    Abdel-Moneim A; Ramadan H
    Drug Dev Res; 2022 Apr; 83(2):301-316. PubMed ID: 34859477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopolymeric nanocarrier: an auspicious system for oral delivery of insulin.
    Panigrahy SK; Kumar A
    J Biomater Sci Polym Ed; 2022 Nov; 33(16):2145-2164. PubMed ID: 35773232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of biodegradable polymeric systems for oral insulin delivery.
    Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
    Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of oral insulin delivery strategies (OIDS).
    Iyer G; Dyawanapelly S; Jain R; Dandekar P
    Int J Biol Macromol; 2022 May; 208():565-585. PubMed ID: 35346680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology in Insulin Delivery for Management of Diabetes.
    Bahman F; Greish K; Taurin S
    Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral insulin-delivery system for diabetes mellitus.
    Kanzarkar M; Pathak PP; Vaidya M; Brumlik C; Choudhury A
    Pharm Pat Anal; 2015 Jan; 4(1):29-36. PubMed ID: 25565158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.
    Kaklotar D; Agrawal P; Abdulla A; Singh RP; Mehata AK; Singh S; Mishra B; Pandey BL; Trigunayat A; Muthu MS
    Nanomedicine (Lond); 2016 Jun; 11(11):1465-86. PubMed ID: 27171572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Improve Insulin Delivery through Oral Route: A Review.
    Bhattacharya R; Johnson AP; Shailesh T; Rahamathulla M; H V G
    Curr Drug Deliv; 2022; 19(3):317-336. PubMed ID: 34288838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery.
    Hu Q; Luo Y
    Int J Biol Macromol; 2018 Dec; 120(Pt A):775-782. PubMed ID: 30170057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in nanoparticles for the treatment of diabetes.
    Sharma DK; Pattnaik G; Behera A
    J Drug Target; 2023 Dec; 31(9):908-919. PubMed ID: 37725445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of polymeric nanoparticles and micelles in insulin oral delivery.
    Alai MS; Lin WJ; Pingale SS
    J Food Drug Anal; 2015 Sep; 23(3):351-358. PubMed ID: 28911691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in polymeric devices for oral insulin delivery.
    Babu VR; Patel P; Mundargi RC; Rangaswamy V; Aminabhavi TM
    Expert Opin Drug Deliv; 2008 Apr; 5(4):403-15. PubMed ID: 18426382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.
    Souto EB; Souto SB; Campos JR; Severino P; Pashirova TN; Zakharova LY; Silva AM; Durazzo A; Lucarini M; Izzo AA; Santini A
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31756981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in buccal and oral delivery of insulin.
    Elsayed A; Al-Remawi M; Jaber N; Abu-Salah KM
    Int J Pharm; 2023 Feb; 633():122623. PubMed ID: 36681204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral insulin delivery: how far are we?
    Fonte P; Araújo F; Reis S; Sarmento B
    J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Natural and Synthetic Polymers in Formulating Micro and Nanoparticles for Anti-Diabetic Drugs.
    Al-Hashimi N; Babenko M; Saaed M; Kargar N; ElShaer A
    Curr Drug Deliv; 2021; 18(3):271-288. PubMed ID: 32778027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery.
    Seyam S; Nordin NA; Alfatama M
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33066443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.